Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

interchem pty ltd - ketamine hydrochloride - unknown - ketamine hydrochloride anaesthetic active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

abbey laboratories pty ltd - ketamine hydrochloride - unknown - ketamine hydrochloride anaesthetic active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

mavlab pty. ltd. - ketamine hydrochloride - unknown - ketamine hydrochloride anaesthetic active 0.0 - active constituent

Zimbabwe - English - Medicines Control Authority

rotexmedica gmbh - ketamine hydrochloride - injectable; injection - 50mg/ml

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

avet health limited - ketamine hydrochloride - unknown - ketamine hydrochloride anaesthetic active 0.0 - active constituent

Uganda - English - National Drug Authority

umedica laboratories pvt ltd - ketamine hydrochloride - parenteral ordinary vials - 50mg/ml

Uganda - English - National Drug Authority

psychotropics india ltd- - ketamine hydrochloride - parenteral ordinary vials - 50mg/ml

United States - English - NLM (National Library of Medicine)

jubilant cadista pharmaceuticals inc. - memantine hydrochloride (unii: jy0wd0ua60) (memantine - unii:w8o17sjf3t) - memantine hydrochloride 5 mg - memantine hydrochloride tablets, usp are indicated for the treatment of moderate to severe dementia of the alzheimer’s type. memantine hydrochloride tablets are contraindicated in patients with known hypersensitivity to memantine hydrochloride or to any excipients used in the formulation. pregnancy category b there are no adequate and well-controlled studies of memantine in pregnant women. memantine hydrochloride should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. memantine given orally to pregnant rats and pregnant rabbits during the period of organogenesis was not teratogenic up to the highest doses tested (18 mg/kg/day in rats and 30 mg/kg/day in rabbits, which are 9 and 30 times, respectively, the maximum recommended human dose [mrhd] on a mg/m2  basis). slight maternal toxicity, decreased pup weights and an increased incidence of non-ossified cervical vertebrae were seen at an oral dose of 18 mg/kg/day in a study in which rats were given oral memantine

Israel - English - Ministry of Health

pharma medis - ketamine as hydrochloride - solution for injection / infusion - ketamine as hydrochloride 50 mg/ml - ketamine - as the sole anaesthetic agent for diagnostic and surgical procedures. when used by intravenous or intramuscular injection, ketamine-hameln is best suited for short procedures. with additional doses, or by intravenous infusion, ketamine-hameln can be used for longer procedures. if skeletal muscle relaxation is desired, a muscle relaxant should be used and respiration should be supported.for the induction of anesthesia prior to the administration of other general anesthetic agents.to supplement other anesthetic agents.specific areas of application or types of procedures:when the intramuscular route of administration is preferred.debridement, painful dressings, and skin grafting in burned patients, as well as other superficial surgical procedures.neurodiagnostic procedures such as pneumoencephalograms, ventriculograms, myelograms, and lumbar punctures.diagnostic and operative procedures of the eye, ear, nose, and mouth, including dental extractions.note: eye movements may persist during ophthalmological procedures. anaesthesia in poor-risk patients with depression of vital functions or where depression of vital functions must be avoided, if at all possible. orthopaedic procedures such as closed reductions, manipulations, femoral pinning, amputations, and biopsies. sigmoidoscopy and minor surgery of the anus and rectum, circumcision and pilonidal sinus. cardiac catheterization procedures.caesarian section; as an induction agent in the absence of elevated blood pressure. anaesthesia in the asthmatic patient, either to minimise the risks of an attack of bronchospasm developing, or in the presence of bronchospasm where anaesthesia cannot be delayed.

Ireland - English - HPRA (Health Products Regulatory Authority)

sintetica ireland limited - esketamine - solution for injection/infusion - 25 milligram(s)/millilitre - esketamine